Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1761 USD | -0.56% | -5.32% | +21.11% |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
Mar. 28 | Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.91M |
---|---|---|---|---|---|
Net income 2022 | -62M | Net income 2023 | -59M | EV / Sales 2022 | - |
Net Debt 2022 | 108M | Net Debt 2023 | 134M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-0.11
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.69% |
1 day | -0.56% | ||
1 week | -5.32% | ||
Current month | -5.48% | ||
1 month | +9.99% | ||
3 months | +2.98% | ||
6 months | +42.02% | ||
Current year | +21.11% |
Managers | Title | Age | Since |
---|---|---|---|
Dennis P. Riley
FOU | Founder | - | 08-12-31 |
J. Sorensen
CEO | Chief Executive Officer | 67 | 12-10-31 |
Robert Beardsley
FOU | Founder | 63 | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Beardsley
FOU | Founder | 63 | 08-12-31 |
Michael Powell
CHM | Chairman | 69 | 16-11-27 |
Kevin Lokay
BRD | Director/Board Member | 67 | 19-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.1761 | -0.56% | 1,030,306 |
24-05-09 | 0.1771 | -0.51% | 325,186 |
24-05-08 | 0.178 | +1.19% | 180,157 |
24-05-07 | 0.1759 | +1.68% | 308,860 |
24-05-06 | 0.173 | -6.99% | 346,920 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+21.11% | 9.58M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- GRTX Stock